Von Willebrand Disease: Range of the Disease, and Management

被引:0
|
作者
Fernández K.S. [1 ]
de Alarcón P.A. [1 ,2 ]
机构
[1] Department of Pediatrics, Division of Hematology/Oncology, Children’s Hospital of Illinois, University of Illinois College of Medicine at Peoria, 530 NE Glen Oak Ave, Peoria, IL
[2] William H. Albers Professor and Chair, Department of Pediatrics, University of Illinois College of Medicine, Peoria, IL
关键词
Children; Management; Von Willebrand disease (VWD);
D O I
10.1007/s40124-013-0035-3
中图分类号
学科分类号
摘要
Von Willebrand disease is the most common autosomal inherited bleeding disorder. It is caused by quantitative or qualitative defects of the von Willebrand factor. The International Society of Thrombosis and Hemostasis recognizes three types of Von Willebrand disease, with four qualitative subtypes, i.e. six different groups in total. All variants present with mucocutaneous bleeding of variable severity depending on the penetrance of the disease, the level of von Willebrand factor (VWF), and the specific abnormality of the defect, resulting in altered VWF interactions between either platelets and collagen or factor VIII. Diagnosis is difficult because the clinical and laboratory phenotypes are very heterogeneous and may overlap for normal subjects. The molecular pathology of the condition corresponds to the specific variants but has a wide range of genetic mechanisms. Accurate diagnosis of the disorder is of critical importance to establish appropriate treatment options for individual patients. This review covers the pathophysiology and genetics of the condition, the diagnostic classification, testing, and the available treatments, specifically highlighting the population. © 2013, Springer Science + Business Media New York.
引用
收藏
页码:60 / 70
页数:10
相关论文
共 50 条
  • [31] New development in von Willebrand disease
    Castaman, Giancarlo
    CURRENT OPINION IN HEMATOLOGY, 2013, 20 (05) : 424 - 429
  • [32] Molecular diagnosis of von Willebrand disease
    Baronciani, L.
    Goodeve, A.
    Peyvandi, F.
    HAEMOPHILIA, 2017, 23 (02) : 188 - 197
  • [33] Von Willebrand disease: Clinical conundrums
    Leebeek, F. W. G.
    Susen, S.
    HAEMOPHILIA, 2018, 24 : 37 - 43
  • [34] VON-WILLEBRAND DISEASE IN CHILDHOOD
    SCHNEPPENHEIM, R
    THOMAS, KB
    SUTOR, AH
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1995, 21 (03): : 261 - 275
  • [35] Von Willebrand factor testing ratios in the diagnosis and subtyping of von Willebrand disease
    Smock, Kristi J.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 23 - 29
  • [36] Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome
    Stufano, Francesca
    Boscarino, Marco
    Bucciarelli, Paolo
    Baronciani, Luciano
    Maino, Alberto
    Cozzi, Giovanna
    Peyvandi, Flora
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2019, 45 (01): : 36 - 42
  • [37] Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand disease
    Favaloro, Emmanuel J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (01) : 114 - 118
  • [38] Targeting von Willebrand disease: the current status and future directions of management therapies
    Franchini, Massimo
    Focosi, Daniele
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (11) : 871 - 878
  • [39] Patients with von Willebrand disease in China: Results of an online survey
    Yang, Wen
    Bi, Hui
    Wang, Xiuli
    Yang, Zhichun
    Wang, Yacan
    Tan, Yaxian
    Wang, Honghui
    Xie, Dongmei
    Mu, Hongli
    Yin, Lingmei
    Zhou, Zeping
    HAEMOPHILIA, 2023, 29 (01) : 230 - 239
  • [40] von Willebrand Disease: Local Diagnosis and Management of a Globally Distributed Bleeding Disorder
    Favaloro, Emmanuel J.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2011, 37 (05): : 440 - 455